Dr. Maki brings nearly 20 years of biotechnology and pharma business development expertise as Company rapidly advances its powerful LNP platform to deliver mRNA-based therapies MENLO PARK, Calif. & ...

Entering 2026, India's pharmaceutical industry initiates a crucial five-year plan to evolve into an innovation hub, aiming ...

China's pharmaceutical sector is playing an increasingly important role on the global stage, with cross-border licensing and ...

MM+M held its third in-person Media Summit at Convene in New York City on Wednesday. The daylong leadership conference touched on numerous topics relevant to medical marketers, pharma executives and ...

At Bayer, a groupwide restructuring is being rolled out as a top priority. But, to Juergen Eckhardt, M.D., who leads both the investment arm Leaps by Bayer and the pharma business development team, ...

LYON, France--(BUSINESS WIRE)--Brenus Pharma, a biotech company specializing in the development of cancer vaccines, announces the completion of a $25 million Series A financing round. The round is led ...

In his first public appearance as Incyte’s CEO, Bill Meury outlined his priorities for the company, which include taking a “fresh look” at the business’ R&D, operating expenses and capital allocation.

Mandy Vink, VP of Business Development at Codexis, explains how the company leverages over 20 years of expertise in small-molecule APIs to advance biocatalysis across pharma.

WASHINGTON — Redwire is making a bigger push into space pharmaceutical development with a new business entity devoted to the field. Redwire announced Aug. 4 the creation of SpaceMD, an entity that ...

Bain Capital has agreed to acquire Mitsubishi Chemical Group’s pharmaceutical business for more than $3 billion, a deal that ...

As someone who has spent years working across both the technical and commercial sides of life sciences manufacturing, I've had a front-row seat to how global supply chain pressures are reshaping ...

The pharmaceutical industry is a major player in the overall life science sector, responsible for developing and manufacturing the majority of prescription drugs. Companies in this space are ...